Stem-rich injections are now available for patients facing painful conditions. This represents a potential advance in pain management for patients suffering from back, neck, arm and leg pain.
For decades, the gold standard for pain management has been steroid injections for spinal or limb pain problems. These cortisone injections work well with excellent results in 75% of the time. However, steroid injections do not change the course of arthritis or soft tissue damage. They simply provide pain relief for a limited period of time and then need to be repeated as usual. There are also serious restrictions on the frequency with which corticosteroid injections can be given due to potential adrenal and blood sugar problems. Most pain doctors recommend that injections should not be more than once every few months, and if multiple joints are injected, the total amount of steroids that enter the body can be quickly picked up.
The Holy Grail of arthritis and soft tissue damage has long been found in cell repair injections that relieve pain and help regenerate bone and soft tissue. Steroid injections only help in areas that relieve pain. Non-steroidal and anti-inflammatory stem cell injections treated from amniotic fluid can not only regenerate cartilage and soft tissue, but also relieve pain.
Regenerative effects have been demonstrated in both laboratory and animal studies. Cartilage defects can be filled with real cartilage. What you are seeing now is that cartilage defects are usually filled with pseudocarbon, also known as fibrocartilage. In the long run, it is not as durable as natural cartilage. Non-steroidal stem cell therapy products are made from living donor amniotic fluid and are neither fetal nor embryonic. Stem cells that enter a substance are not pluripotent. That is, it cannot differentiate stem cell center scottsdale in all types of cells. However, it can differentiate into most cell types, such as bone, muscle, and cartilage, which are most important for orthopedic injections and pain management.
Allogeneic implants from human amniotic membrane have been used more than 4,000 times in the United States in recent years. Indications include soft tissue injections, spinal fusion enhancement, wound healing, degenerative joint disease, joint injections, and peri-spinal injections as a barrier to scarring. The adverse events of this potentially renewable drug were minimal and the results were promising.
Today, regenerative medicine injections are becoming more and more popular. Major t.o.v